145 related articles for article (PubMed ID: 3032757)
1. Effect of dihydroergocryptine and dihydroergocristine on cyclic AMP accumulation and prolactin release in vitro: evidence for a dopaminomimetic action.
Fiore L; Scapagnini U; Canonico PL
Horm Res; 1987; 25(3):171-7. PubMed ID: 3032757
[TBL] [Abstract][Full Text] [Related]
2. D-2 dopamine receptor activation reduces free [3H]arachidonate release induced by hypophysiotropic peptides in anterior pituitary cells.
Canonico PL
Endocrinology; 1989 Sep; 125(3):1180-6. PubMed ID: 2527149
[TBL] [Abstract][Full Text] [Related]
3. Dopamine and bromocriptine inhibit cyclic AMP accumulation in the anterior pituitary: the effect of cholera toxin.
Cronin MJ; Thorner MO
J Cyclic Nucleotide Res; 1982; 8(4):267-75. PubMed ID: 6300209
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
Enjalbert A; Bockaert J
Mol Pharmacol; 1983 May; 23(3):576-84. PubMed ID: 6306429
[TBL] [Abstract][Full Text] [Related]
5. Physiological concentrations of dopamine decrease adenosine 3',5'-monophosphate levels in cultured rat anterior pituitary cells and enriched populations of lactotrophs: evidence for a causal relationship to inhibition of prolactin release.
Swennen L; Denef C
Endocrinology; 1982 Aug; 111(2):398-405. PubMed ID: 6284477
[No Abstract] [Full Text] [Related]
6. The dopamine agonist, PHNO ((+)-4-propyl-9-hydroxynaphthoxazine), inhibits cyclic adenosine 3',5'-monophosphate formation and prolactin release from anterior pituitary cells.
Login IS; Trugman JM
Neuropharmacology; 1989 Jun; 28(6):647-50. PubMed ID: 2547181
[TBL] [Abstract][Full Text] [Related]
7. Effects of dopamine on prolactin secretion and cyclic AMP accumulation in the rat anterior pituitary gland.
Ray KP; Wallis M
Biochem J; 1981 Jan; 194(1):119-28. PubMed ID: 6171257
[TBL] [Abstract][Full Text] [Related]
8. Receptor reserve for D2 dopaminergic inhibition of prolactin release in vivo and in vitro.
Meller E; Puza T; Miller JC; Friedhoff AJ; Schweitzer JW
J Pharmacol Exp Ther; 1991 May; 257(2):668-75. PubMed ID: 1674531
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of prolactin release and blockade of adenohypophyseal cell cyclic AMP accumulation are two dissociable effects of dopaminergic and non-dopaminergic drugs.
Lafond J; Ducharme JR; Collu R
Mol Cell Endocrinol; 1986 Mar; 44(3):219-25. PubMed ID: 3007237
[TBL] [Abstract][Full Text] [Related]
10. c-AMP levels decreased by dopamine in cultured rat pituitary lactotrophs.
Swennen L; Denef C
Arch Int Pharmacodyn Ther; 1982 Apr; 256(2):315-6. PubMed ID: 6179484
[No Abstract] [Full Text] [Related]
11. Dopaminergic receptors in the anterior pituitary gland. Correlation of [3H]dihydroergocryptine binding with the dopaminergic control of prolactin release.
Caron MG; Beaulieu M; Raymond V; Gagné B; Drouin J; Lefkowitz RJ; Labrie F
J Biol Chem; 1978 Apr; 253(7):2244-53. PubMed ID: 416027
[No Abstract] [Full Text] [Related]
12. Pertussis toxin uncouples dopamine agonist inhibition of prolactin release.
Cronin MJ; Myers GA; MacLeod RM; Hewlett EL
Am J Physiol; 1983 May; 244(5):E499-504. PubMed ID: 6682634
[TBL] [Abstract][Full Text] [Related]
13. Actions of dopamine on prolactin secretion and cyclic AMP metabolism in ovine pituitary cells.
Ray KP; Wallis M
Mol Cell Endocrinol; 1982 Jul; 27(2):139-55. PubMed ID: 6180941
[TBL] [Abstract][Full Text] [Related]
14. Second messengers associated with the action of AII and dopamine D2 receptors in anterior pituitary. Relationship with prolactin secretion.
Bockaert J; Journot L; Enjalbert A
J Recept Res; 1988; 8(1-4):225-43. PubMed ID: 2838617
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic inhibition of prolactin release and calcium influx induced by neurotensin in anterior pituitary is independent of cyclic AMP system.
Memo M; Castelletti L; Missale C; Valerio A; Carruba M; Spano PF
J Neurochem; 1986 Dec; 47(6):1689-95. PubMed ID: 2430058
[TBL] [Abstract][Full Text] [Related]
16. Pertussis toxin blocks the inhibitory effect of muscarinic cholinergic agonists on cyclic AMP accumulation and prolactin secretion in GH3 anterior-pituitary tumour cells.
Brown BL; Wojcikiewicz RJ; Dobson PR; Robinson A; Irons LI
Biochem J; 1984 Oct; 223(1):145-9. PubMed ID: 6093766
[TBL] [Abstract][Full Text] [Related]
17. The possible involvement of both calcium and cyclic AMP in the dopaminergic inhibition of prolactin secretion.
Merritt JE; Brown BL
Life Sci; 1984 Aug; 35(7):707-11. PubMed ID: 6206370
[TBL] [Abstract][Full Text] [Related]
18. [3H]Dihydroergocryptine binding in anterior pituitary and prolactin secretion: further evidence of brain regulation of adenohypophyseal receptors.
Libertun C; Larrea GA; Vacas MI; Cardinali DP
Endocrinology; 1980 Dec; 107(6):1905-9. PubMed ID: 6775933
[TBL] [Abstract][Full Text] [Related]
19. Effects of estradiol on prolactin production and dihydroergocryptine-induced inhibition of prolactin production in primary cultures of rat pituitary cells.
West B; Dannies PS
Endocrinology; 1980 Apr; 106(4):1108-13. PubMed ID: 6766855
[No Abstract] [Full Text] [Related]
20. In vitro studies on basal and stimulated prolactin release by rat anterior pituitary: a possible role for calmodulin.
Schettini G; Judd AM; MacLeod RM
Endocrinology; 1983 Jan; 112(1):64-70. PubMed ID: 6291923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
